Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More
Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More
Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More

Fluorion Covidenza kit has been developed for the detection and discrimination of SARS-CoV-2, Influenza A and Influenza B viruses from RNA samples obtained from patients.

The positive control in the kit is synthetic DNA. It contains target regions of the N1, N2, M2, NS1 and RNAseP genes that are amplified only with the primer-probe sets included in this kit. The content of the positive control tube is not infectious.

More Information

Fluorion Covidenza +, developed for Qualitative detection and discrimination of Coronavirus 2019 (COVID-19) SARS CoV-2, Influenza A, Influenza B, RSV and Rhinovirus viruses in patients with COVID-19, influenza or common cold like symptoms (e.g. fever, cough, shortness of breath), using lower respiratory tract (bronchoalveolar lavage (BAL), tracheal aspirate and/or upper respiratory tract (nasopharyngeal and oropharyngeal fluids, nasal swab samples.)

More Information

Highlights

Why Fluorion Covidenza or Covidenza+

Testing is one of the most crucial steps in tackling the Coronavirus pandemic, which is why we have developed the Fluorion Covidenza Kit. The kit has been developed for the detection and discrimination of SARS-CoV-2, Influenza A, and Influenza B viruses from swab samples obtained from patients.

Professional’s opinion

Not every respiratory infection is Covid. The right diagnosis is the critical requirement for proper treatment. Evidence-based treatment based on PCR tests, is our most important tool against respiratory tract infectious diseases. Fast, Easy, Accessible.

M. Cengiz Yakicier, MD, PhD,
Molecular Biology and Genetic Acıbadem
Pathology & Head of Aquarius Genetic Center

Dean of Acıbadem University Faculty of Art and Science (2013-2021)
Acıbadem Hospital, Head of Molecular Biology and Genetics Department (2013-2021)

Have questions about
Fluorion Covidenza?

We love to hear from you about your questions, comments and anything related to our products and services.
Please do not hesitate to drop us a message and we will get back to you as soon as possible.

Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More
Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More
Slide One test
for all
for detection and discrimination of COVID-19, SARS CoV-2, Influenza A, Influenza B, RSV and Rhinoviruses *

* Covidenza +
Highlights Read More

Fluorion Covidenza kit has been developed for the detection and discrimination of SARS-CoV-2, Influenza A and Influenza B viruses from swab samples obtained from patients.

The positive control in the kit is synthetic DNA. It contains target regions of the N1, N2, M2, NS1 and RNAseP genes that are amplified only with the primer-probe sets included in this kit. The content of the positive control tube is not infectious.

More Information

Fluorion Covidenza +, developed for Qualitative detection and discrimination of Coronavirus 2019 (COVID-19) SARS CoV-2, Influenza A, Influenza B, RSV and Rhinovirus viruses in patients with COVID-19, influenza or common cold like symptoms (e.g. fever, cough, shortness of breath), using lower respiratory tract (bronchoalveolar lavage (BAL), tracheal aspirate and/or upper respiratory tract (nasopharyngeal and oropharyngeal fluids, nasal swab samples.)

More Information

Highlights

Why Fluorion Covidenza or Covidenza+

Testing is one of the most crucial steps in tackling the Coronavirus pandemic, which is why we have developed the Fluorion Covidenza Kit. The kit has been developed for the detection and discrimination of SARS-CoV-2, Influenza A, and Influenza B viruses from swab samples obtained from patients

Professional’s opinion

Not every respiratory infection is Covid. The right diagnosis is the critical requirement for proper treatment. Evidence-based treatment based on PCR tests, is our most important tool against respiratory tract infectious diseases. Fast, Easy, Accessible.

M. Cengiz Yakicier, MD, PhD,
Molecular Biology and Genetic Acıbadem
Pathology & Head of Aquarius Genetic Center

Dean of Acıbadem University Faculty of Art and Science (2013-2021)
Acıbadem Hospital, Head of Molecular Biology and Genetics Department (2013-2021)

Have questions about
Fluorion Covidenza?

We love to hear from you about your questions, comments and anything related to our products and services.
Please do not hesitate to drop us a message and we will get back to you as soon as possible.